Mitochondrial function - Role in insulin resistance and lipid metabolism;Mitochondrienfunktion - Auswirkungen auf insulinresistenz und lipidmetabolismus

Acta Medica Austriaca

Volumn 31, Issue 4, 2004, Pages 115-119

  Lechleitner, Monika ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Insulin resistance; Mitochondrial function

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FATTY ACID; FIBRIC ACID DERIVATIVE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MALONYL COENZYME A; METFORMIN; UNCOUPLING PROTEIN;

AGING; CONFERENCE PAPER; EXERCISE; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIA; MULTIENZYME COMPLEXES; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS;

EID: 9144247001     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Ferrannini E (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocrin Rev 19: 477-490
2. Beck-Nielsen H, Vaag A, Poulsen P, Gaster M (2003) Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects - experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 17: 445-467
3. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607
4. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants (2004) Definition of metabolic syndrome. Circulation 109: 433-438
5. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116
6. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Järvinen H (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87: 3023-3028
7. Ruderman N, Prentki M (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature 3: 340-351
8. Listenberger LL, Han X, Lewis SE, Cases S, Farese RVjr, Ory DS, Schaffer JE (2003) Triglyceride accumulation protects against fatty-acid induced lipotoxicity. Proc Nat Acad Sci USA 100: 3077-3083
9. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C (1991) Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88: 960-966
10. Hegarty BT, Furler SM, Ye J, Cooney GJ, Kraegen EW (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178: 373-383
11. McGarry JD (2002) Banting lecture: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18
12. Unger RH (2002) Lipotoxic diseases. Annu Rev Med 53: 319-336
13. Gerbitz KD, Gempel K, Brdiczka D (1996) Mitochondria and diabetes: genetic, biochemical and clinical implications of the cellular energy circuit. Diabetes 45: 113-126
14. Unger RH and Orci L (2001) Disease of liporegulation: new perspectives on obesity related disorders. FASEB J 15: 312-321
15. Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950
16. Essig DA (1996) Contractil activity-induced mitochondrial biogenesis in skeletal muscle. Exerc Sport Sci Rev 24: 289-314
17. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, Di Pietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142
18. Patti ME (2004) Gene expression in humans with diabetes and prediabetes: what we learned about diabetes pathophysiology? Curr Opin Clin Nutr&Metabolic Care 7: 383-390
19. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair SK (2003) Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 100: 7996-8001
20. Barazzoni R (2004) Skeletal muscle mitochondrial protein metabolism and function in aging and type 2 diabetes. Curr Opin Clin Nutr&Metabolic Care 7: 97-102
21. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offsprings of patients with type 2 diabetes. N Engl J Med 350: 664-671
22. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, Nair SK (2003) Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52: 1888-1896
23. Leverve XM, Guigas B, Detaille D, Batandier C, Koceir EA, Chauvin C, Fontaine E, Wiernsperger NF (2003) Mitochondrial metabolism and type-2 diabetes: a specific target for metformin. Diabetes Metab 29: 6S88-94
24. Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, Roden M, Gnaiger E, Nohl H, Waldhausl W, Furnsinn C (2004) Thiazolidindiones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53: 1052-1059
25. Saha AK, Kurowski TG, Colca JR, Ruderman NB (1995) A malonyl-CoA fuel sensing mechanism in muscle: effects of insulin, glucose, and denervation. Am J Physiol 269: E283-E289
26. Heydrick SJ, Ruderman NB, Kurowski TG, Adams HB, Chen KS (1991) Enhanced stimulation of diacylglycerol an lipid-synthesis by insulin in denervated muscle. Altered proteinkinase C activity and possible link to insulin resistance. Diabetes 40: 1707-1711
27. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE (1992) Malonyl-CoA and long-chain Acyl-CoA esters as metabolic coupling factors in nutrient - induced insulin secretion. J Biol Chem 267: 5802-5810
28. Hu Z, Cha SH, Chohnan S, Lane MD (2003) Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc Natl Acad Sci 100: 12624-12629
29. Hardie DG, Scott JW, Pan DA, Hudson ER (2003) Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120
30. Minokoshi Y et al (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated proteinkinase. Nature 415: 339-343
31. Yamauchi T et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med 8: 1288-1296
32. Zhou G et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174
33. Fryer LG, Parbu-Patel A, Carling D (2002) The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signalling pathways. J Biol Chem 277: 25226-25232
34. Ferre P, Azzout-Marniche D, Foufelle F (2003) AMP-activated protein kinase and hepatic genes involved in glucose metabolism. Biochem Soc Trans 31: 220-223
35. Dalgaard LT, Pedersen O (2001) Uncoupling proteins functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 44: 946-965
36. Thompson MP, Kim D (2004) Links between fatty acids and expression of UCP2 and UCP3 mRNAs. FEBS Lett 568: 4-9
37. Tuomilheto J, Lindstrom J, Eriksson JG, Valle TT, Harmalainen H, Ilanne-Parikka P, Keinanen-Kiukaaniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350
38. Diabetes Prevention Research Group (2002) Reduction in the evidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med 346: 393-403
39. Irrcher I, Adhihetty PJ, Joseph AM, Ljubicic V, Hood DA (2003) Regulation of mitochondrial biogenesis in muscle by endurance exercise. Sports Med 33: 783-793
40. Newcomer BR, Larson-Meyer DE, Hunter GR, Weinsier RL (2001) Skeletal muscle metabolism in overweight and post-overweight women: an isometric exercise study using (319P magnetic resonance spectroscopy. Int J Obes Relat Metab Disord 25: 1309-1315
41. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS-34) Lancet 352: 854-865
42. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37: 1202-1219
43. Seli E, Duleby AJ (2004) Treatment of PCOS with metformin and other insulin-sensitizing agents. Curr Diab Rep 4: 61-75
44. Gervois P, Torra IP, Fruchart JC, Staels B (2000) Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin Chem Lab Med 38: 3-11
45. Cabrero A, Alegret M, Sanchez RM, Adzet T, Laguna JC, Vasquez M (2001) Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes 50: 1883-1890
46. Brunmait B, Lest A, Staniek K, Gras F, Scharf N, Roden M, Nohl H, Waldhausl W, Furnsinn C (2004) Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. J Pharmacol Exp Ther
47. Olsen GS, Hansen BF (2002) AMPkinase activation ameliorates insulin resistance induced by free fatty acids in skeletal muscle. Am J Physiol Endocrinol Metab 283: E965-970